๐Ÿ•ต๏ธ Kailera Therapeutics, Inc. ($KLRA)

SEC insider & ownership activity, last 12 months ยท CIK 2096997 ยท every row links its SEC filing

Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.

Insider flow

5 buyers, value withheld pending verification (5 lots) ยท 0 sellers, $0 (0 lots)

InsiderBuysBoughtSellsSoldLast
BAIN Capital Life Sciences Investors, LLC1value withheld pending verification 0โ€“Apr 20, 2026
RTW Investments, LP1value withheld pending verification 0โ€“Apr 20, 2026
BAIN Capital Investors LLC1value withheld pending verification 0โ€“Apr 20, 2026
Andrew T. Kaplan1value withheld pending verification 0โ€“Apr 20, 2026
Koppel Adam1value withheld pending verification 0โ€“Apr 20, 2026

5%+ holders

HolderStakeClassScheduleEvent
BCPE Perseus Investor, LP 20.3% 13DApr 16, 2026 filing โ†—
BCLS Fund IV Investments, L.P. 17.4% 13DApr 16, 2026 filing โ†—
Jiangsu Hengrui Pharmaceuticals Co., Ltd. 8.9% 13GAug 5, 2026 filing โ†—
RTW Investments, LP 8.3% 13GAug 14, 2026 filing โ†—
Roderick Wong 8.3% 13GAug 14, 2026 filing โ†—
CPP Investment Board Private Holdings (4) Inc. 5.6% 13GAug 14, 2026 filing โ†—
Canada Pension PLAN Investment Board 5.6% 13GAug 14, 2026 filing โ†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Earnings (2.02)Aug 12, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 12, 2026 filing โ†—
Earnings (2.02)May 26, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 26, 2026 filing โ†—
Charter/bylaw changes (5.03)Apr 20, 2026 filing โ†—
Other events (8.01)Apr 20, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 20, 2026 filing โ†—